O
Olaf H. Drummer
Researcher at Monash University
Publications - 309
Citations - 12302
Olaf H. Drummer is an academic researcher from Monash University. The author has contributed to research in topics: Poison control & Captopril. The author has an hindex of 56, co-authored 304 publications receiving 11326 citations. Previous affiliations of Olaf H. Drummer include Monash University, Clayton campus & University of Western Australia.
Papers
More filters
Journal ArticleDOI
Validation of new methods.
TL;DR: Important considerations in analytical method validation will be discussed and may be used as guidance by scientists wishing to develop and validate analytical methods.
Journal ArticleDOI
Dose related risk of motor vehicle crashes after cannabis use
TL;DR: Combined use of THC and alcohol produced severe impairment of cognitive, psychomotor, and actual driving performance in experimental studies and sharply increased the crash risk in epidemiological analyses, suggesting that recent use of cannabis may increase crash risk, whereas past use of Cannabis does not.
Journal ArticleDOI
The involvement of drugs in drivers of motor vehicles killed in australian road traffic crashes
Olaf H. Drummer,Jim Gerostamoulos,Helen P Batziris,M-L Chu,John R. M. Caplehorn,Michael D. Robertson,Philip Swann +6 more
TL;DR: There were non-significant, weakly positive associations of opiates and benzodiazepines with culpability, and drivers showing the highest culpability rates were in the under 25 and over 65 age groups.
Journal ArticleDOI
The incidence of drugs in drivers killed in Australian road traffic crashes
Olaf H. Drummer,Jim Gerostamoulos,Helen P Batziris,Mark Chu,John R. M. Caplehorn,Michael D. Robertson,Philip Swann +6 more
TL;DR: The incidence of alcohol and drugs in fatally injured drivers were determined in three Australian states; Victoria, New South Wales and WA for the period of 1990-1999 and the prevalence of drugs increased over the decade, particularly cannabis and opioids, while alcohol decreased.
Journal ArticleDOI
Central Sleep Apnea in Stable Methadone Maintenance Treatment Patients
David Wang,Harry Teichtahl,Olaf H. Drummer,Cathy Goodman,Gaye Cherry,David Cunnington,Ian Kronborg +6 more
TL;DR: Thirty percent of stable MMT patients have CSA, a minority of which can be explained by blood methadone concentration, and other physiologic variables may also play a role in the pathogenesis of CSA in M MT patients, and further research is indicated.